Ulcerative pyoderma gangrenosum

CMAJ. 2019 Sep 23;191(38):E1058. doi: 10.1503/cmaj.190721.

Authors

Megan Sander¹, Michael Sander²

Affiliations

¹ Department of Medicine (Megan Sander) and Cumming School of Medicine (Michael Sander), University of Calgary, Calgary, Alta. megan.a.sander@gmail.com.
² Department of Medicine (Megan Sander) and Cumming School of Medicine (Michael Sander), University of Calgary, Calgary, Alta.

No abstract available

Publication types

Case Reports

MeSH terms

Cyclosporine / therapeutic use
Female
Humans
Immunosuppressive Agents / therapeutic use
Leg
Lupus Erythematosus, Systemic / complications
Middle Aged
Pyoderma Gangrenosum / complications
Pyoderma Gangrenosum / diagnosis*
Pyoderma Gangrenosum / drug therapy
Pyoderma Gangrenosum / pathology

Substances

Immunosuppressive Agents
Cyclosporine